Medtronic Seeking Preliminary Injunction Against J&J For MiniCrown Stent
This article was originally published in The Gray Sheet
Executive SummaryMedtronic AVE plans to ask the U.S. District Court of Delaware to hear a motion for a preliminary injunction against Johnson & Johnson to prohibit the continued manufacture, use and sale of J&JCordis division's MiniCrown stent delivery system.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.